This research grant supports the careers of junior investigators interested in PAH research. Each year, PHA grants one award to a promising researcher likely to make a strong, sustained impact in PAH research.
Proposals should examine the pathophysiology of PAH to clarify mechanistic pathways and identify new therapeutic targets or biomarkers in adult or pediatric pulmonary hypertension. The project potentially should apply to human pulmonary vascular diseases.
Applicants may request up to $40,000 a year for two years. The funds can cover salaries and/or supplies. Indirect costs won’t be paid to sponsoring institutions.
PHA encourages investigators to connect through its professional network, PH Clinicians and Researchers, during their research.
Apply by 5 p.m. ET, March 15 2022. Review the policies and guidelines for eligibility and submission instructions.
Sponsorship support provided by Janssen Pharmaceuticals Inc. through a partnership with PHA.
Questions? Contact us.